To document the effects of intravitreal dexamethasone implant on retinal microvasculature in patients with diabetic retinopathy complicated by center-involving macular edema.
Methods
35 eyes of 35 patients affected by retinopathy due to type 2 diabetes (15 treatment-naïve and 20 previously treated) were included in this retrospective study with a follow-up of 4 months. Foveal avascular zone (FAZ) area and superficial capillary plexus (SCP) and deep capillary plexus (DCP) densities in the foveal and parafoveal areas were measured by optical coherence tomography angiography (OCTA) at baseline and 2 and 4 months post-injection. Intraocular pressure, morphological and functional parameters were evaluated.
Results
a significant difference was found in both groups at 2 months after injection in terms of functional (BCVA, p < 0.05) and morphological (CMT, p < 0.05) parameters. During follow-up, FAZ area, SCP, and DCP in the foveal and parafoveal areas did not change significantly.
Conclusions
intravitreal dexamethasone implant is effective in the treatment of diabetic center-involving macular edema and was associated with significant improvements in BCVA and CMT at 2 months after injection. After a single dexamethasone implant injection, FAZ area and retinal vascular density does not show significant variations in both naive and non-naive DME patients subgroups.
VujosevicSBiniSMidenaG,et al.Hyperreflective intraretinal spots in diabetics without and with nonproliferative diabetic retinopathy: an in vivo study using spectral domain OCT. J Diabetes Res2013; 2013: 491835.
8.
DaruichAMatetAMoulinA, et al.Mechanisms of macular edema: beyond the surface. Prog Retin Eye Res2018; 63: 20–68.
9.
FunatsuHNomaHMimuraT, et al.Association of vitreous inflammatory factors with diabetic macular edema. Ophthalmology2009; 116: 73–79.
10.
MendisKRBalaratnasingamCYuP, et al.Correlation of histologic and clinical images to determine the diagnostic value of fluorescein angiography for studying retinal capillary detail. Invest Ophthalmol Vis Sci2010; 51: 5864–5869.
11.
PanozzoGCicinelliMVAugustinAJ, et al.An optical coherence tomography-based grading of diabetic maculopathy proposed by an international expert panel: the European School for Advanced Studies in Ophthalmology classification. Eur J Ophthalmol2020; 30: 8–18.
12.
OrCSabrosaASSorourO,et al.Use of OCTA, FA, and ultra-widefield imaging in quantifying retinal ischemia: a review. Asia Pac J Ophthalmol2018; 7: 46–51.
13.
WellsJAGlassmanARAyalaAR, et al.Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial. Ophthalmology2016; 123: 1351–1359.
14.
BoyerDSYoonYHBelfortRJr, et al.Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology2014; 121: 1904–1914.
15.
SaraoVVerittiDBosciaF,et al.Intravitreal steroids for the treatment of retinal diseases. ScientificWorldJournal2014; 2014: 1–14.
16.
BresslerNMOdiaIMaguireM, et al.Association between change in visual acuity and change in central subfield thickness during treatment of diabetic macular edema in participants randomized to aflibercept, bevacizumab, or ranibizumab: a post hoc analysis of the protocol T randomized clinical trial. JAMA Ophthalmol2019; 137: 977–985.
17.
SunJKLinMMLammerJ,et al.Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema. JAMA Ophthalmol2014; 132: 1309–1316.
18.
VujosevicSTorresinTBiniS,et al.Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema. Acta Ophthalmol2017; 95: 464–471.
Chang-LinJEAttarMAcheampongAA, et al.Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci2011; 52: 80e86.
21.
WilkinsonCPFerrisFL3rdKleinRE, et al.Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology2003; 110: 1677–1682.
22.
Medina-BaenaMCejudo-CorbalánOGarcía-PulidoJI,et al.Intravitreal dexamethasone implant in naive and previously treated patients with diabetic macular edema: a retrospective study. Int J Ophthalmol2020; 13: 1597–1605.
23.
ÖzataKAtumMÇelikE,et al.Efficacy of intravitreal dexamethasone implant in persistent diabetic macular edema after primary treatment with intravitreal ranibizumab. J Curr Ophthalmol2019; 31: 281–286. doi: 10.1016/j.joco.2019.03.002
24.
GillAColeEDNovaisEA, et al.Visualization of changes in the foveal avascular zone in both observed and treated diabetic macular edema using optical coherence tomography angiography. Int J Retina Vitreous2017; 3: 19.
25.
BoyerDSYoonYHBelfortRJr, et al.Ozurdex MEAD study group. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology2014; 121: 1904–1914.
26.
PanozzoGGussonEPanozzoG,et al.Dexamethasone intravitreal implant for diabetic macular edema: indications for a PRN regimen of treatment. Eur J Ophthalmol2015; 25: 347–351.
27.
SaraoVVerittiDFurinoC,et al.Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular oedema: six-month outcomes of the UDBASA study. Acta Ophthalmol2017; 95: e255–e260.
28.
RosenblattAUdaondoPCunha-VazJ, et al.A collaborative retrospective study on the efficacy and safety of intravitreal dexamethasone implant (ozurdex) in patients with diabetic macular edema: the European DME registry study. Ophthalmology2020; 127: 377–393.
29.
HallerJAKuppermannBDBlumenkranzMS, et al.Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. Arch Ophthalmol2010; 128: 289e296.
30.
TotoLD'AloisioRDi NicolaM, et al.Qualitative and quantitative assessment of vascular changes in diabetic macular edema after dexamethasone implant using optical coherence tomography angiography. Int J Mol Sci2017; 18: 1181.
31.
SacconiRCorbelliECarnevaliA, et al.Optical coherence tomography angiography in pseudophakic cystoid macular oedema compared to diabetic macular oedema: qualitative and quantitative evaluation of retinal vasculature. Br J Ophthalmol2018; 102: 1684–1690.
32.
IshibazawaANagaokaTTakahashiA,et al.Optical coherence tomography angiography in diabetic retinopathy: a prospective pilot study. Am J Ophthalmol2015; 160: 35–44.e1. e1.
33.
AgemySAScripsemaNKShahCM, et al.Retinal vascular perfusion density mapping using optical coherence tomography in normals and diabetic retinopathy patients. Retina2015; 35: 2353–2363.
34.
SpaideRF. Retinal vascular cystoid macular edema: review and new theory. Retina2016; 36: 1823–1842.
